SeerPharma Pty Ltd :: DISCover web-based training :: Atrial Fibrillation: Treatment

Atrial Fibrillation: Treatment

Description: Atrial fibrillation (AF), also called "a-fib," is the most common cardiac arrhythmia. The hallmarks of AF are irregular and rapid atrial activity, with an irregular ventricular response that results in compromised cardiac hemodynamics. AF is associated with serious morbidity and increased mortality risk, even in cases when symptoms are slight. AF is a risk for congestive heart failure (CHF), angina, cardiac remodeling, and embolic stroke. This course outlines the treatment options for patients with AF.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Stroke Risk
6. Cardiovascular Events
7. Gender Differential
8. Progress Check

TREATMENT I
9. Objectives
10. Restoring Normal Sinus Rhythm
11. Antiarrhythmic Classes
12. Electrical Cardioversion
13. Antiarrhythmic Drugs
14. Device Therapy
15. Surgery

TREATMENT II
16. Hybrid Therapy
17. AV Nodal Blocking Drugs
18. AV Node Ablation
19. Preventing Blood Clots
20. Stroke Prevention: Risks and Benefits
21. New Approaches
22. Progress Check

CONCLUSION
23. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

Discuss the stroke risk in patients with AF
Identify common outcomes of AF
List the concerns associated with AF treatment
Summarize the risks and benefits of anticoagulation therapy for stroke prevention in AF patients
Distinguish between treatment for rate control and rhythm control in AF and explain the related issues

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.